• Regenerative Medical Technology Group’s wholly owned Global Stem Cells Group began Cellgenic commercial activity in Peru via local arrangements.
• Move extends Cellgenic’s Latin American network, with Peru part of a three-market growth push alongside Brazil and Colombia.
• Management flagged no expectation that the Peru arrangements will be material, with revenue impact uncertain.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609010701ACCESSWRNAPR_____1214899) on September 01, 2026, and is solely responsible for the information contained therein.